Decoding Mounjaro Dosing: Understanding Milligrams, Milliliters, and Why Units Don’t Apply

Last reviewed: July 15, 2026

Last updated: July 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, the active ingredient in medications like Mounjaro, comes in specific concentrations that often confuse patients trying to understand their prescription. The difference between milligrams (mg), milliliters (mL), and units matters significantly when you're learning how to dose correctly and what to expect from your treatment plan.

What Is Tirzepatide and How Does Concentration Matter

Tirzepatide is a dual GIP and GLP-1 receptor agonist developed to help regulate appetite and blood sugar. When tirzepatide is prepared by licensed 503A compounding pharmacies, it's mixed at specific concentrations—meaning a set amount of active drug dissolved in a specific volume of liquid. Understanding this concentration directly impacts how you'll measure and inject your dose each week.

The concentration of a tirzepatide injection determines how many milligrams of the actual drug are in each milliliter of solution. For example, if your prescription is 5 mg/mL, then one milliliter of that solution contains exactly 5 milligrams of tirzepatide. This relationship is critical because your healthcare provider prescribes a dose in milligrams, but you measure and inject in milliliters using a syringe.

Milligrams Versus Milliliters: Understanding the Difference

Milligrams measure the actual amount of drug in your injection—this is what your prescriber increases over time as your body adjusts to treatment. Milliliters measure volume, or the physical amount of liquid you draw into your syringe each week. These are two completely different measurements, which is why confusion happens so easily.

When you hold a tirzepatide vial, the label shows concentration in mg/mL. If your dose is 2.5 mg and your vial is labeled 5 mg/mL, you would draw 0.5 mL into your syringe. The milliliter amount you inject stays tied to the concentration of the vial, so changing your dose in milligrams will also change how many milliliters you draw—but not because the liquid itself changed, but because you're using a different concentration or drawing a larger volume of the same concentration.

Why Units Don't Apply to Tirzepatide Dosing

Tirzepatide is measured and dosed strictly in milligrams, never in units. Units are used for medications like insulin, where one unit represents a standardized amount of biological activity. Tirzepatide's potency is measured by its molecular weight in milligrams, so prescribers always write doses as 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg—never as 'units per kilogram' or any unit-based scale.

This distinction matters if you've previously taken insulin or other unit-based medications, because the dosing logic is entirely different. With tirzepatide from licensed 503A compounding pharmacies, your prescriber adjusts your dose in clear milligram increments, and PlexusDx keeps your monthly cost flat regardless of dose level—your dose may need to go up, but your price won't.

How PlexusDx Tirzepatide Injections Simplify Your Treatment

PlexusDx partners with licensed 503A compounding pharmacies to prepare personalized tirzepatide injections tailored to your starting dose and titration schedule. When you begin treatment, your healthcare provider establishes a dose escalation plan—typically starting at 2.5 mg weekly and increasing by 2.5 mg every four weeks until reaching your therapeutic dose. PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) and remains that price as your dose increases, simplifying both your medical care and your budget.

Beyond standard dosing, PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway genetic assessment that examines variants in GIPR, GLP1R, FTO, and MC4R genes to map 14 metabolic pathways and 49 peptides. This insight helps your healthcare provider understand your individual response tendencies to tirzepatide therapy, allowing for more precise personalization of your treatment plan from the very beginning.

Common Dosing Schedules and What to Expect

Most patients on tirzepatide follow a standard titration schedule starting at 2.5 mg once weekly. After four weeks at that dose, if tolerated well, the dose increases to 5 mg weekly. This pattern continues with 2.5 mg increases every four weeks: 7.5 mg, 10 mg, 12.5 mg, and finally 15 mg as the maximum maintenance dose. Your prescriber may adjust this timeline based on your individual response, side effects, or weight loss progress.

PlexusDx serves all 50 states without requiring insurance, membership fees, or health plan approval—and your tirzepatide prescription qualifies for HSA and FSA payment, making it accessible regardless of your coverage situation. As your dose climbs from week to week, the milliliter amount you inject may change, but your monthly investment in treatment remains fixed, removing cost uncertainty from your weight loss journey.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

If my tirzepatide dose increases, will the milliliters I inject always increase too?

Not necessarily—it depends on the concentration of your vial. If your vial is labeled 5 mg/mL and your dose increases from 2.5 mg to 5 mg, you'd draw 0.5 mL to 1 mL respectively. However, if your pharmacy prepares a higher-concentration vial as you escalate, you might draw fewer milliliters for the same milligram increase. Your prescriber or PlexusDx healthcare team will clarify exactly how many milliliters to draw at each dose level.

Why doesn't tirzepatide use units like insulin does?

Tirzepatide's potency is based on its chemical structure and molecular weight, measured in milligrams. Insulin uses units because its activity is defined by blood glucose-lowering effect standardized across different preparations. Tirzepatide is always dosed by milligram amount, making prescribing clearer and reducing the risk of dosing errors that can happen with unit-based systems.

Will my monthly cost at PlexusDx increase as my tirzepatide dose goes up?

No. PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) and remains that flat price across all dose levels during your treatment. Your dose may need to go up, but your price won't—this pricing structure removes financial barriers as you optimize your therapy and reach your therapeutic target dose.

How do I know if I'm drawing the correct milliliter amount for my tirzepatide dose?

Your vial label shows the concentration in mg/mL, and your prescription specifies your dose in milligrams. Divide your dose in mg by the concentration in mg/mL to calculate milliliters: for example, 5 mg ÷ 5 mg/mL = 1 mL. PlexusDx and your prescriber provide clear injection instructions with your first shipment, and you can always call to confirm your calculation before injecting.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Why Do Some People Tolerate Dairy While Others Don T Is It Genetic
• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.